1. Predictors of physical morbidity and mortality in people with schizophrenia
- Author
-
Berry, Alexandra, Drake, Richard, Webb, Roger, Ashcroft, Darren, Carr, Matthew, and Yung, Alison
- Subjects
Cardiovascular disease ,Sleep ,Schizophrenia ,Physical health - Abstract
Whilst past research has highlighted the substantial gap in mortality and morbidity among people with schizophrenia compared with the general population, it was previously unknown whether sleep problems or sedentary behaviour are linked with the cardiovascular health of people with schizophrenia. I hypothesised that people with schizophrenia would have poor sleep and high levels of sedentary behaviour and that these will be driving their increased prevalence of cardiovascular disease (CVD), independent of well-known CVD risk factors such as blood pressure and body mass index. Secondly, I hypothesised that treating health professionals will be unaware of these risk factors in this group, and will not be intervening, as a result of a lack of clinical guidance and standardised measurement tools. My research was conducted using a varied range of methods, including quantitative and qualitative studies, as well as systematic reviews, ensuring a comprehensive approach. Study 1 provided an overview of the literature among people with schizophrenia, examining the association between sleep problems and increased weight, a component of metabolic syndrome and known risk factor for cardiovascular disease (CVD). This study revealed mixed findings, likely due to a lack of standardised measurement for sleep problems. Study 2 aimed to provide some clarity, by examining the prevalence of major cardiovascular events among people with schizophrenia, with and without sleep problems, sedentary behaviour and muscular weakness in a large, longitudinal cohort of volunteers (UK Biobank). Findings from Study 2 suggested a raised prevalence of major cardiovascular events among participants with daytime sleepiness and muscular weakness, independent of known risk factors. However, Study 3 revealed low levels of knowledge regarding sleep problems as a risk factor for CVD among mental healthcare professionals supporting people with schizophrenia. Study 4 showed that sleep problems and muscular weakness are not accounted for in CVD risk prediction calculators, as data on these risk factors are not routinely collected within primary care databases, and also that agreement is poor between CVD risk calculators validated for severe mental illness (SMI) populations. Studies 1-4 emphasise the need for validated measures of lifestyle risk factors, including sleep problems, that are feasible for routine clinical use. Whilst Study 2 found no difference in prevalence of major cardiovascular events among people with schizophrenia with and without sedentary behaviour, this may have been related to a reporting issue. Thus, there is also a need to establish a feasible and validated measure of sedentary behaviour among people with schizophrenia. The final study (Study 5) examined the feasibility and validity of novel tools that measure these risk factors by comparing wrist- and waist-worn ActiGraph wGT3X-BT accelerometers with the SleepBot smartphone app and the five-item Simple Physical Activity Questionnaire (SIMPAQ). The acceptability of these tools was assessed during qualitative interviews with the participants. The findings of my doctoral research demonstrate the importance of healthcare professionals monitoring lifestyle factors such as sleep problems and sedentary behaviour among people with schizophrenia to improve their health outcomes. This can be achieved with accelerometry for measuring sleep and either accelerometry or the SIMPAQ for measuring physical activity and sedentary behaviour. Routine monitoring will allow the development and validation of bespoke CVD risk calculators that include these lifestyle factors for SMI populations.
- Published
- 2021